Sholzberg, Michelle; Tang, Grace H; Rahhal, Hassan; AlHamzah, Musaad; Kreuziger, Lisa Baumann; Áinle, Fionnuala Ní; Alomran, Faris; Alayed, Khalid; Alsheef, Mohammed; AlSumait, Fahad; Pompilio, Carlos Eduardo; Sperlich, Catherine; Tangri, Sabrena; Tang, Terence; Jaksa, Peter; Suryanarayan, Deepa; Almarshoodi, Mozah; Castellucci, Lana A; James, Paula D; Lillicrap, David; ... (2021). Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ, 375, n2400. BMJ Publishing Group 10.1136/bmj.n2400 BMJ. British Medical Journal (Online), 375 The BMJ The BMJ, 375:n2400. British Medical Association
The New England Journal of Medicine, 385, 9, pp. 790-802 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2021, 385 (9), pp.790-802. ⟨10.1056/NEJMoa2105911⟩ The New England journal of medicine New England journal of medicine, 385(9), 790-802. Massachussetts Medical Society et al. 2021, ' Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 ', New England Journal of Medicine, vol. 385, no. 9, pp. 790-802 . https://doi.org/10.1056/NEJMoa2105911 NEW ENGLAND JOURNAL OF MEDICINE Investigators, REMAP-CAP & Dark, P 2021, ' Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. ', The New England Journal of Medicine, vol. 385, no. 9, pp. 790-802 . https://doi.org/10.1056/NEJMoa2105911 The New England Journal of Medicine The New England Journal of Medicine, 385, 790-802